About

I’m an immunologist specializing in T cell biology and epigenetic regulation of immune responses. I earned my doctorate at the Salk Institute, studying transcription factor–driven chromatin remodeling in CD8⁺ T cells during infection and cancer.

Background

NewLimit 2023–present

Developing medicines for age-related disease.

Salk Institute · UC San Diego 2018–2023

Ph.D. Thesis: Canonical BAF complex activity licenses effector and memory CD8⁺ T cell fates, with Drs. Susan Kaech and Diana Hargreaves.

Bristol Myers Squibb 2016–2018

Tumor immunology, including Fc-optimized anti-CCR8 antibodies for depleting tumor regulatory T cells.

La Jolla Institute for Immunology 2012–2016

Innate and T cell immunity to cytomegalovirus, with Dr. Chris Benedict.

Links